XLO

Conviction 55HealthcareScan · Mon, Jul 20, 2026

Bearish marubozu

XLO$8.55-3.77%

ResistanceSupportVol 14

Vol MA14 61.37K

Apr 20May 6May 26Jun 11Jul 1Jul 20

Xilio Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.xiliotx.com ↗

Price8.55

Change-3.77%

Gap-0.34%

Rel volume1.11×

Avg volume57.22K

Avg $ vol522.35K

SMA 209.11

SMA 508.56

SMA 2004.05

Price vs 50-0.15%

Price vs 200+111.12%

MA stackmixed

50/200 cross—

Supertrendup · 7.94

RSI (14)42

MACD hist-0.10

MACD crossbear · 6d

Stoch %K / %D0 / 21

ADX (14)19

+DI / −DI17 / 19

RSI divergence—

MACD divergence—

ATR %+4.68%

ADR %4.06%

52w high9.58

52w low0.5101

From 52w high-10.80%

Above 52w low+1575.16%

New 52w highNo

SqueezeOn · 4d

Bollinger width9.74%

%B-0.14

Donchian pos3.24%

Donchian high9.89

Donchian low8.50

AVWAP (52w high)9.12

vs AVWAP high-6.26%

AVWAP (52w low)6.12

vs AVWAP low+39.61%

OBV trendDown

Chaikin MF (20)0.09

Today vs 20d1.11×

Avg vol (14d)61.37K

Avg vol (20d)57.22K

Avg $ vol (20d)522.35K

Market cap49.41M

RS 3m (vs SPY)+0.41%

RS 6m (vs SPY)+1267.37%

RS line new highNo

Trend template7/8

Technical rank73.8

1 week-7.52%

1 month-2.34%

3 months-0.29%

6 months+1234.95%

1 year+1078.62%

YTD+1172.15%

P/E-1.41

P/B0.68

P/S1.13

P/FCF-8.97

EPS-4.19

Div yield—

ROE-48.30%

ROA-21.43%

Debt/Eq—

Current3.59

EV/EBITDA2.50

Gross margin—

Net margin-80.05%

Rev growth589.88%

EPS growth39.84%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-100.92M

Revenue12.65M

Net income-9.53M

Gross profit—

Free cash flow-5.51M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out6.58M

Employees76

ListedFri, Oct 22, 2021

Free float30.47M

Float %45.1%

Short interest174.62K

Days to cover3.6d

Short volume68.1%

Squeeze score40 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.58 vs −$0.66

Last surprise+12.1% beat

Setup gradeC

Conviction55 / 100

Pattern quality—

Tech rank73.8 / 100

Group rank23 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish marubozu

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in XLO

All disclosures →

No recent disclosed trades by Congress in XLO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in XLO · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Blanchard Cheryl R Director · Stock Option (right to buy) · 2026-04-15	Grant	10K	$0	2026-04-15	2026-04-16

SEC filings

EDGAR filings in XLO · 1 recent

EDGAR →

8-K8-KMaterial eventFri, Jun 12, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.